PER 1.18% 8.4¢ percheron therapeutics limited

Ann: Chief Executive Officer and Managing Director Appointment, page-91

  1. 720 Posts.
    lightbulb Created with Sketch. 210
    JG doesn’t start in the role for four months (Sep 7th). In the meantime CG will be running the ship and JG attending the board meetings as a consultant. He obviously wanted a healthy break between jobs.

    Coincidentally, Sep 7th is the one year anniversary of the revamped P2b trial announcement.

    They have based his sign on option award of 6,690,000 options (1% of the company at present if all exercised) on the 5 day VWAP before this announcement (about 7.5c) as he wouldn’t want to sign up now to the SP in 4 months time when it could be a lot higher (hint hint).

    The announcement is a bit vague on what the exercise prices will be, as they only refer to the “value”.

    September 2023 is also a coincidence as it marks when ANP no longer have any IONIS patents (all expired, or not renewed).

    Big changes in the last 9 months which could be out of desperation, or hopefully more likely, CG has a cunning plan and there’s positive things going on that we can’t be made aware of at this time.

 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.4¢
Change
-0.001(1.18%)
Mkt cap ! $75.72M
Open High Low Value Volume
8.4¢ 8.4¢ 8.3¢ $3.097K 37.23K

Buyers (Bids)

No. Vol. Price($)
1 29206 8.3¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 118557 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.